The value of ONS Value Ons

In this study by Kiesswetter E. et al. 2026, a network meta‑analysis compared oral nutrition interventions to determine which most effectively improve outcomes in malnourished hospitalised older adults.

Prof. Dr. Agathe Raynaud-Simon at the 44th Congress of the European Society of Clinical Nutrition and Metabolism (ESPEN), 2022. This lecture will focus on patient-related and intervention-related factors that influence compliance, recovery from malnutrition, and other clinical outcomes in older malnourished patients. 

Dr Karen Freijer presents at the 44th Congress of the European Society of Clinical Nutrition and Metabolism (ESPEN), 2022. During this session, the burden of disease related malnutrition – with a focus on older adults– together with cost savings of optimal nutrition intervention and the importance of nutrition economics, will be discussed. 

Prof. Leocadio Rodríguez Mañas presents at the 44th Congress of the European Society of Clinical Nutrition and Metabolism (ESPEN), 2022 on the role of nutritional status on function in older adults living in community, the role of key nutrients and effective interventions.

As part of the Satellite Symposium at 46th ESPEN Congress on Clinical Nutrition and Metabolism, Milano, Italy, Prof. Phillips discusses the importance of protein, specific amino acids and the role they play in muscle mass physiology.

MNA® (Mini Nutritional Assessment) is a validated nutrition screening/assessment tool to identify individuals 65 year and above who are malnourished or at risk of malnutrition. The online resource utilises a number of questions which patients answer and provides them with a score at the end in which they can determine what category they fit into whether they have: a normal nutritional status, at risk of malnutrition or malnourished.

Presented by Dr. Jane Winter, Accredited Practising Dietitian, this presentation helps us understand the extent of Malnutrition in the community, for us to be familiar with strategies to identify and recognize Malnutrition and to understand range of interventions available.

Lee SY, Lee HJ, Lim JY. Effects of leucine-rich protein supplements in older adults with sarcopenia: A systematic review and meta-analysis of randomized controlled trials. Arch Gerontol Geriatr. 2022 Sep-Oct;102:104758.   Data from six randomised controlled trials including a total of 699 participants, demonstrate that the consumption of leucine-rich protein supplements (offering 3-6g leucine per day) can improve muscle strength, muscle mass and performance in sarcopenic older adults compared to a control group (P<0.001) and may be suggested as a nutritional treatment for sarcopenia.

This exciting initiative across a select range rolls out from March with full availability by August. Find out more information here. Download Resource Plus Product Information Sheet

A national, anonymous 41-question, online purpose-designed survey explores whteher older adults understand and value muscle health, tjheir avility to take action and overall knowledge and confidence to manage their health.

Li ML, Zhang F, Luo HY, Quan ZW, Wang YF, Huang LT, Wang JH. Improving sarcopenia in older adults: a systematic review and meta-analysis of randomized controlled trials of whey protein supplementation with or without resistance training. J Nutr Health Aging. 2024 Apr;28(4):100184   Results from Ten randomised control trial studies including 1154 participants, demonstrate the value of whey protein (9.6-40g per day) supplementation in adults with sarcopenia. When compared to Isocaloric placebo (PLA)/Routine consultation (RC) group, whey protein consumption significantly increased appendicular skeletal muscle mass index and muscle mass in addition to gait speed.